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Summary.-A previously described defect of in vitro monocyte maturation in patients
with squamous-cell carcinoma of the lung (SCC) has been investigated further. The
maturation of patients' monocytes in pooled normal human serum was significantly
better than in autologous serum. Conversely, the maturation of normal control
monocytes was significantly depressed in patients' serum. The defect has been shown
to be due to the presence of an inhibitory factor, rather than the lack of a necessary
component in the patients' serum.
Artificially aggregated y-globulin inhibited monocyte maturation in vitro, but the
presence of immune complexes in the serum of many patients with SCC did not
correlate well with the depression of in vitro maturation of monocytes from the same
patient. Similarly, pregnancy-associated a22-glycoprotein, in increased amounts in
the serum of patients with SCC, showed no correlation with monocyte maturation.
The addition of soluble extracts of tumour, but not of surrounding normal lung tissue
significantly inhibited monocyte maturation.
The results suggest that the defective monocyte maturation in patients with SCC
is at least in part due to serum inhibitory factors, which are likely to be a hetero-
geneous group.
ABNORMAL FUNCTIONING of cells of the
mononuclear phagocytic system (MPS) is
commonly found in patients with cancer,
particularly disseminated cancer. In a
previous publication (Dent & Cole, 1981)
we described a deficiency in the ability of
monocytes from patients with squamous-
cell carcinoma ofthe lung (SCC) to mature
into macrophages in vitro. Similar defects
in monocyte maturation have previously
been reported in patients with malignant
melanoma (Currie & Hedley, 1977) and
breast carcinoma (Taylor & Currie, 1979).
In all 3 studies the abnormality has been
more marked in those with extensive
disease.
There is considerable evidence that
soluble serum factors are important in the
genesis of disordered lymphocyte function
in tumour-bearers, and more recently it
has been suggested that similar mechan-
isms may be the basis of abnormal MPS
function. Monocyte chemotaxis is depres-
sed in the presence of soluble tumour
factors (Maderazo et al., 1978) and the
formation of macrophage-precursor colon-
ies is poor in the presence of serum from
tumour-bearers (Liu et al., 1979). Also, in
vitro phagocytosis of a test emulsion by
monocytes is poor in the presence of
serum from patients with a variety of
solid tumours (Pisano et al., 1972).
We have investigated the importance
of serum factors in the poor monocyte
maturation observed previously in pat-
ients with SCC. We have also examined
the influence ofsoluble extracts oftumour
and aggregated y-globulins on this assay.
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PATIENTS, MATERIALS AND METHODS
Patients.-The study group comprised
patients with definite SCC admitted to
Brompton or London Chest Hospitals be-
tween June 1978 and November 1979. They
were divided into those with limited disease
(confined to one lung with or without hilar-
node involvement) and those with more
extensive disease (involving the mediastinum,
contralateral lung or supraclavicular nodes,
with or without distant metastases). Twenty
patients with limited and 20 with extensive
disease were studied. Control patients com-
prised 60 with no chest disease, 33 with
chronic obstructive airways disease (COAD)
and 10 with terminal non-malignant disease,
as previously described (Dent & Cole, 1981).
Pooled normal human serum (NHS).-This
was prepared from the pooled sera of 20
normal volunteers. The serum was separated
in sterile plastic universals at 370C, and
stored in lml aliquots at -70°C until
required.
Monocyte maturation.-The assay was per-
formed as described previously (Dent &
Cole, 1981). Briefly, defibrinated peripheral
blood was layered on a mixture of Ficoll and
Triosil (sp. gr. 1 077) and the mononuclear
cells collected from the interface following
centrifugation at 500 g for 35 min at room
temperature. The cells were washed x 5 and
adjusted to a concentration of 4 x 106/ml in
RPMI 1640 (Flow Laboratories, Irvine) sup-
plemented with L-glutamine (2 mM), penicillin
(100 u/ml), streptomycin (100 ,ug/ml) and
HEPES buffer (Gibco Europe, Glasgow) to a
final concentration of 0-02 M. Fifty pul of cell
suspension and 50 jud of serum were added to
the wells of microtitre plates (Nunclon Delta,
Denmark) and incubated at 370C in a humidi-
fied atmosphere of 5% C02 in air. Cytospin
preparations (Shandon Southern) were made
of the same cell suspensions and stained for
non-specific esterase (NSE) (Yam et al., 1971).
From these preparations the percentage of
monocytes was estimated, a total of 300 cells
being counted in each case.
After 7 days, each well was washed with
medium to remove any non-adherent cells,
and the remaining cells were counted as
described previously (Dent & Cole, 1981).
Monocyte maturation was then calculated as
the number of mature macrophages per well
at Day 7, as a percentage of the number of
monocytes placed in each well at Day 1. The
mean of5 wells was taken in each case.
Monocyte adherence.-Two 1d of 2 x 106/ml
mononuclear cells in 50% serum were placed
in each of 10 wells on microtitre plates and
incubated for 2 h at 370C in a humidified
atmosphere of 5% C02 in air. Each well was
washed x 3 with medium and the number of
cells adhering to the bottom of each well
counted, and expressed as a percentage of
NSE+ cells originally placed in each well.
The 2h adherent populations were shown to
consist of monocytes, with negligible ( <1%)
granulocyte contamination, by staining for
NSE and chloracetate esterase (Yam et al.,
1971).
Immune complexes.-Polyethylene glycol
precipitation was based on the method des-
cribed by Creighton et al. (1973) and later by
Chia et al. (1979). Four hundred ,ul of serum
was mixed with 120 ul of DL-dithiothreitol
(Sigma; 5 ,ug/ml) and 1360 1l of PBS EDTA
(0-01 M) and incubated for 15 min at 37°C.
One hundred and twenty tkl of H202 (0.2%)
was added to each tube and mixed. Two ml
of 7% polyethylene glycol (PEG) was added
to each tube to give a final concentration of
3-5% PEG After incubation for 18 h at 40C,
the precipitated material was separated by
centrifugation at 9000 g for 20 min and
redissolved in 100 ,u of borate buffer. The
levels of immunoglobulin £G, A and M and of
C3 and C4 were determined by single radial
immunodiffusion (Mancini et al., 1965).
Results were expressed as a percentage ofthe
total in untreated serum (derived from serum
levels).
The conglutinin-binding assay was based
on that described by Casali et al. (1977) with
some adaptations. Bovine conglutinin was
prepared (Lachmann & Hobart, 1978) and
further purified by chromatography on
DEAE cellulose. Two hundred and fifty ,ul of
a 5,4g/ml conglutinin preparation was added
to each well of a microelisa plate. The plate
was covered with parafilm and foil and stored
at 40C for at least 48 h. After washing x 3 in
VBS-Tween 20 (0-025%) (Difco Laboratories
Ltd, Detroit, Michigan) 250 pl of serum,
diluted 1:100 or standard, was added to each
well and the plates incubated for 3 h at 21 0C.
After 3 further washes, 250 ,ul of conjugate
(anti-IgG-alkaline phosphatase 1:4000, Miles
Yeda Ltd, Kiryot Weizmann, Rehovat,
Israel) was added to each well and the plate
incubated for 3 h at 210C. A further wash
with VBS-Tween was followed by adding
200 ,ul of substrate p-nitro-phenyl phosphate
523R. G. DENT ANI) P. J. COLE
(Signma) in carbonate buffer. At 30 rnin, 3N
NaOH wvas added to each wN-ell to stop the
reaction. UV absorption at 409 nm was
recorded, and complex levels Nere calculated
from a calibration curve constructed using
preparations ofalkaline-aggregated y-globulin
in fresh NHS.
For both PEG precipitation and conglu-
tinin binding, immune complexes wTere con-
sidered present if the levels measured
exceeded the mean level established in 60
normal volunteers by > 2 s.d.
Pregnancy-associated oX2-glycoprotein, (PAG).
PAG levels were kindly measured by Drs
I. Hunter and W. H. Stimson of Strathelyde
University using a method described pre-
viously (Stimson, 1978).
Preparation of aggregated y-globulin (AGG)
and its influence on monocyte maturation.-A
20mg/ml solution of y-globulin Cohn fraction
11 (Sigma Chemical Company, St Louis,
Mass.) was mixed with an equal volume of
0-2M NaOH and allowed to stand for 10 min.
Dialysis against PBS at room temperature for
2 h was followed by a similar dialysis over-
night. The AGG was stored at 4°C until
required. Concentration wvas determined by
UV absorbance at 280 nm. AGG or unaggre-
gated y-globulin was added to the wells of
microtitre plates with the cell suspension to
give a final concentration of 0-400 Mug/ml,
and monocyte maturation wvas measured as
described above. In a further study, the
inonocytes were exposed to y-globulin for 30
min, Awashed 2 x in medium and distributed to
wells of microtitre plates for measurement of
monocyte maturation in50%o serum.
Preparation of tissue extracts and their
influence on monocyte maturation.-Tumour
and surrounding lung tissues removed at
operation wvere taken fresh to the laboratory
and 30g pieces finely minced with scissors and
homogenized in RPMI 1640 containing 1000
foetal calf serum (FCS) using a glass homo-
genizer. The preparations were spun at
8000 g for 15 min and the supernatants
stored in 2ml aliquots at -70°C until
required. Ten yul of tumour or lung extract
was added to each well of microtitre plates,
in addition to 50 ju of2 x 106/ml mononuclear
cells and 50 1ul of serum, and monocyte
maturation performed. Control wvells con-
tainied an additional 10 yul of medium or 1000
FCS. In parallel experiments, mononuclear
cells were exposed to the extracts or control
medium at a final concenitration of 10% in
siliconized glassware for 30 min, wAashed 2 x
in medium and their concentration readjusted
to 2 x 106 in RPMI 1640 and 50%/ serum
before (listribution to microtitre plates for the
measurement of maturation.
RESULTS
The effect of serum on monocyte maturation
Maturation of monocytes from the 40
patients with SCC was performed in
parallel in autologous serum and NHS.
The results shown in Fig. 1 demonstrate
that monocyte maturation was significant-
ly better in NHS than in autologous serum
from patients with both limited (P < 0.005)
and extensive (P < 0 005) disease. Similar
60 -
50 -
40 -
r_
._
c' 30-
20 -
10 -
Limited squamous
cell carcinoma
P< 0.005
PS NHS
Extensive squamous
cell carcinoma
P< 0.005
PS NHS
Serum
Ii. I. Jo vitro rnaturation of monocytes
firom patients with squamous-cell carcinoma
of the lung performect simultaneously in
eithler 50%o atitologouis serum (PS) or 50%o
p)ooled normal lhuman seruim (NHS).
Dashed bars represent means. Significance
of dlifference betwe-en means for PS ancl
NHS estimated by WAilcoxoni ranke(d
matched pairs test.
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parallel studies in 10 patients with termin-
al non-malignant disease showed that
mean maturation of monocytes from such
patients in autologous serum was 19-2%
(range 7.4-42.2%) with no improvement
when cultured in NHS (mean 21.5%;
range 3-6-42.8%).
The influence of serum on the matura-
tion of normal monocytes was also
studied. Maturation of a patient's mono-
cytes was always studied in parallel with
the monocytes from at least one normal
control. The normal monocytes were
cultured in autologous serum, NHS and
patients' serum. There was no significant
difference in maturation between mono-
cytes cultured in autologous normal
serum (mean 44.90) and NHS (mean
43-1%). Maturation in serum from patients
I P< 0.001 P<0.001
60 -
50 -
40
-
IR
20 -
10-
TABLE I.-In vitro maturation of mono-
cytes from 4 patients with squamous-cell
carcinoma of the lung: Effect of repeated
washing and different serum source and
concentrationt
Monocyte maturation
(0)
Patient*
Serum source and No. of --_
concentration washes 1 2
50% Autologous 5 12 21
60% Autologous 5 15 20
50% NHS 1 10 14
50% NHS 2 25 20
50% NHS 3 29 22
500o NHS 4 31 37
50% NHS 5 30 25
600% NHS 5 34 39
50% NHS+10% 5 9 25
Autologous
50% Autologous 5 11 16
+10% NHS
* Each result is the mean of 5
NHS =pooledl normal human serum.
3 4 Mean
16
14
12
22
23
26
23
22
17
14-0
14-5
13 -0
21 -5
23 -5
29 -5
29 0
29-0
16 -0
7
9
16
19
20
24
34
21
12
13 12 14 -0
measurements.
with either limited (mean 31 2%) or
extensive (mean 24.6%) SCC was signifi-
cantly lower than the maturation of the
same cells cultured in NHS (P<0 001)
(Fig. 2).
In 4 patients with SCC, a detailed
analysis of the serum effect was under-
taken (Table I). Washing monocytes from
patients with SCC improved subsequent
maturation in NHS for up to 4 washes.
Maturation of monocytes in 50% auto-
logous serum supplemented with 10%
NHS was very similar to that in 50% or
60% autologous serum alone. However,
maturation of monocytes in 50% or 60%
NHS, which in all 4 patients was markedly
better than in 50% autologous serum, was
depressed on the addition of 10% auto-
logous serum.
NHS Limited NBS
Serum
FIG. 2. In vitro maturation of monocy
from normal controls performed sin
taneously in either 50% pooled norn
human serum (NHS) or 60% serum fr
patients with limited or extensive S
Dashed bars represent means. P estima
as in Fig. 1.
The influence of AGG on monocyte matura-
tion
Extive A dose-related inhibition of monocyte
maturation was demonstrated with each of
ytes 4 normal subject's monocytes cultured
nual with AGG (Fig. 3). There was some inhibi-
rom tion of maturation at higher concentra-
cc. tions of unaggregated y-globulin, but this
was minimal comoared with that due to
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100
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_ 40-
20
20 /
0 10 25 50 100 200 400
Concentration of gamma globulin in culture medium (gg/ml)
Fie. 3.-In vitro maturation of 4 sets of
normal monocytes in the presence of 50%
autologous serum and different concentra-
tions of native y-globulin (----) or alka-
line-aggregated y-globulin ( ). Bars
represent s.d. The results are expressed as
% of the result in 50% autologous serum
alone. Difference between points on the 2
curves assessed by analysis of variance:
*=p< 0-001.
TABLE II.-In vitro monocyte adherence
and maturation in normal subjects:
Effect of unaggregated and alkaline-
aggregated y-globulin (AGO)
y-globulint
AGGT
Prior AGG II
Adherence
(2 h)*
102-0+ 6- 4
99 -2 + 3 - 8
100- 9 + 3 - 7
Maturation
(7 days)*
80-0 + 7-8
19-4+6-4 P<0.001§
86 - 9 + 6 -8
t 50% autologous serum with a final concentration
of 200 ,Ig/ml of Cohn Fraction II y-globulin.
1 50% autologous serum with a final concentra-
tion of 200 jug/ml of AGG.
11 50% autologous serum after incubating cells for
30 min in AGG followed by 2 washes in fresh
medium.
* Mean of 4 experiments expressed as % ( s.d.)
ofresult in autologous serum alone.
§ Significance of difference by t test.
similar levels of AGG. A comparison of
adherence and maturation at a concentra-
tion of 200 jg/ml y-globulin (Table II)
revealed no difference in adherence at 2 h,
but markedly reduced numbers of mature
macrophages at 7 days, in the presence of
AGG (P < 0-001). Exposing the monocytes
to AGG for 30 min before washing them
2 x and culturing in normal autologous
serum producd a percentage maturation
marginally but significantly less than
controls.
Immune complexes and monocyte matura-
tion
Eight of the 20 patients with limited
SCC (40%) and 13 ofthe 20 with extensive
SCC (65%) had immune complexes pres-
ent, as assessed by PEG precipitation or
conglutinin binding (Table III). There was
TABLE III.-Immune complexes inpatients
with squamous-cell carcinoma of the lung
Patients
Immune
complex
type
PEG
precipitation
IgG
IgA
IgM
C3
C4
Conglutinin
binding
complexes
Limited Extensive
COAD disease disease
(33) (20) (20)
Numbers with complexes
, ~~~~~~
7
1
2
9
5
}
3
4
1
4
1
2
6
6
3
9
4
6 3
Any (%1) 15 (45) 8 (40) 13 (65)
COAD =chronic obstructive airways disease.
PEG= polyethylene glycol precipitable.
Immune complexes were considered to be present
ifthe level ofPEG precipitate or conglutinin binding
was more than 2 s.d. above the mean for 60 normal
controls, viz:
IgG, 0-9+0-6%; IgA, 1-2+1-0%; IgM, 5-6+7-4%;
C3, 1.2+0-8%; C4, 1-0+1-2%; conglutinin
binding, 9-9 + 9-1 jug/ml.
no significant difference in mean mono-
cyte maturation between those patients
with and without immune complexes. The
level of precipitated IgG, IgA, IgM, C3 or
C4 could not be correlated with the per-
centage monocyte maturation. There was,
however, a weak negative correlation
between the level of conglutinin-binding
complexes and in vitro monocyte matura-
tion (Fig. 4).
Pregnancy-associated o2-glycoprotein (PAG)
and monocyte maturation
The levels of PAG in 5 female patients
with SCC (mean 40 ,ug/ml) was similar to
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FIG. 4.-In vitro maturation of monocytes
from 40 patients with SCC in autologous
serum, related to the level of conglutinin
binding. r8 =Spearman rank correlation
coefficient=-0-41 (P < 0 05).
that in 6 female controls (mean 52 ,ug/ml).
Although the mean PAG levels in male
patients with limited SCC (31.5 jig/ml)
were higher than in the 18 normal male
controls (24-0 ,ug/ml) and 16 patients with
COAD (18-6 ,g/ml), these differences were
not statistically significant. Six of the 20
patients with limited SCC and 4 of the 20
patients with extensive SCC had PAG
levels above the normal range for the
laboratory in which the levels were
measured. There was no difference in
mean monocyte maturation between those
patients with normal and those with
raised PAG levels, and PAG levels did not
correlate with levels of monocyte matura-
tion.
Effects of tumour and lung extracts on
monocyte maturation
The soluble extracts of 4 resected SCC
were tested in parallel with the extract
from an equivalent weight of adjacent
uninvolved lung, and control medium.
Three normal monocyte preparations were
cultured as described under Methods, to
determine monocyte maturation, but add-
ing 10 lzl of tumour extract, lung extract
or RPMI 1640 with 10% FCS to each well.
The tumour extract depressed maturation
in all 4 cases (Table IV) from 35 to 84.4%
of control values (P< 0.001). Two of the 4
extracts ofadjacent lung also caused some
depression (P< 0.05). Adherence at 2 h
was slightly but not significantly lower
than control values whenever tumour or
uninvolved lung supernatant was present.
Exposure to tumour extracts for 30 min,
followed by 2 washes in fresh medium,
produced significant but much less depres-
sion of maturation of monocytes sub-
sequently cultured in autologous serum.
DISCUSSION
In this communication we attempt to
TABLE IV.-In vitro monocyte adherence and maturation in normal subjects: Effect of
extractsfrom resected squamous-cell carcinomas of the lung and from adjacent lung tissue
Adherencet Maturation* Maturation (7 days) after
Tissue extract (2 h) (7 days) prior exposure to extractt
A Lung 95-3 80-6* 96-5
Tumour 90.0 45 -5** 83 9**
B Lung 98-4 107-1 98 - 7
Tumour 89
-0 62-3** 77 0**
C Lung 9858 108-4 97 0
Tumour 93 2 84-4** 92 -8
D Lung 96-4 74.0* 95 2
Tumour 85-8 35.0** 81-8**
Mean Lung 97-2+1-4 (s.d.) 92-5+15-4p<O-00l 96-8±1-2 p< - Tumour 89-5+d2-6 56-8+18-7} 83-9+J5-P7
t In the presence of extracts expressed as % ofresults in autologous serum+FCS.
. In 50% autologous serum after incubation with extracts for 30 min, followed by 2 washes in fresh
medium; expressed as % of result in autologous serum+FCS.
Each result represents the mean of 3 sets of normal monocytes. Significance of difference from control
values (assessed by analysis of variance): * P< 0 05. ** P < 0-001.
A .
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analyse the factors responsible for the
abnormality of in vitro monocyte matura-
tion described in a previous paper (Dent
& Cole, 1981). The defect has been shown
to be due, in part at least, to a serum
factor, since maturation of SCC patients'
monocytes was consistently and statistic-
ally better in NHS than in autologous
serum, and maturation of normal mono-
cytes was depressed in the presence of
patients' serum. The maturation of mono-
cytes from SCC patients could be im-
proved by washing x 4 with medium,
though the result was still well short of
that obtained with monocytes from nor-
mal controls. This suggests the presence of
inhibitory material on the cells which is
removed by thorough washing, though an
alternative explanation could be the
selective loss during successive washes of
monocytes with poor maturation poten-
tial. The evidence from studying 4 sets of
monocytes in detail suggests inhibitory
factor(s) in SCC patients, rather than a
deficiency of something necessary for
normal maturation, since the addition of
just 10%1 of autologous serum to 500%
NHS reduces maturation of patients'
monocytes below that in 5000 or 60°
NHS alone. The residual deficiency in
maturation of monocytes from SCC pati-
ents after repeated washing may be
explained by failure to remove completely
an adherent inhibitory factor or factors, or
alternatively may, as suggested by
Nyholm & Currie (1978), represent a state
of activation of monocytes in cancer
patients.
Most functions of cells of the MPS are
enhanced in tumour-bearers, at least
during early growth, but monocyte chemo-
taxis (Boetcher & Leonard, 1974; Haus-
man et al., 1975) and maturation (Currie
& Hedley, 1977; Taylor & Currie, 1979)
have been consistently reported as de-
pressed. Snyderman & Pike (1976) des-
cribed a low-mol.-wt factor, released by
murine neoplasms, that inhibited macro-
phage chemotaxis both in vivo and in vitro,
and they proposed, as a possible mechan-
ism, an effect on the activation or matura-
tion of moinonuclear phagocytes into
chemotactically responsive cells. Soluble
factors interfering with monocyte chemo-
taxis have also been described in patients
with a variety oftumours (Maderazo et al.,
1978) and monocyte spreading may be
inhibited by sera from tumour-bearing
patients (Laurentaci & Favoino, 1977).
Most work on soluble factors that inter-
fere with cellular immunity has concerned
abnormal lymphocyte function, and a
variety of tumour- and host-derived
materials have been implicated, involving
specific and nonspecific mechanisms. Speci-
fic factors, including tumour antigens,
tumour antibodies and immune complexes
and the evidence for their importance to
lymphocyte function in tumour-bearers,
has been extensively reviewed (Baldwin &
Robins, 1975). Recently it has been sug-
gested that immune complexes may influ-
ence MPS function in tumour-bearers
(Michl et al., 1979; Rao et al., 1979) and in
patients with systemic lupus erythema-
tosus a defect of in vitro monocyte
adherence at 4 days (an assay similar to
that described here) was thought to be
due to the presence of immune complexes
(Svensson, 1975). Aggregated y-globulin
has been shown to inhibit neutrophil
chemotaxis (Kemp et al., 1979), as have
IgA soluble immune complexes (Ito et al.,
1979) and the lysis of red blood cells by
monocytes is inhibited by AGG (Nyholm
& Currie, 1978) in a dose-related fashion
similar to the inhibition of monocyte
maturation by AGG in our experiments.
The evidence that complexes may inter-
fere with maturation is interesting in view
of the prevalence of immune complexes
in SCC, described here and confirmed bv
others in patients with lung carcinomas
(Gropp et al., 1980). However, we were
unable to demonstrate a consistent corre-
lation between the presence of immune
complexes and in vitro monocyte matura-
tion. The weak relation between conglu-
tinin-binding complexes and poor mono-
cyte maturation may reflect a chance
occurrence, since both immune complexes
(Gropp et al., 1980; Theofilopoulos et al.,
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1977) and depressed monocyte matura-
tion (Dent & Cole, 1981) are more common
with increasing extent of the disease.
Alternatively, conglutinin binding may be
a better measure of the type of complex
that binds to monocytes (or is consumed
by them) altering their function, than is
PEG precipitation.
Israel & Edelstein (1978) have empha-
sized the importance of nonspecific in-
hibitors of cellular immune function in
tumour-bearers, either tumour- or host-
derived. One such material, which has
been investigated in some detail, is PAG
(Stimson, 1975); it is found in increased
levels in many patients with tumours,
including lung carcinomas (Bauer et al.,
1977) and suppresses lymphocyte function
(Stimson, 1976). The levels recorded in our
40 SCC patients demonstrated a wide
scatter, as found by previous workers.
However, there was no correlation be-
tween PAG level and monocyte matura-
tion, even when the sexes were considered
separately. Thus we have no evidence that
PAG has any suppressive action on this
aspect of monocyte function.
There is some evidence that the position
locally (within and at the edge oftumours)
may be different from that found systemic-
ally, owing perhaps to the high concentra-
tion of factors produced by the tumour.
The expression of Fe receptors on mono-
cytes, for instance, though enhanced by
serum from patients with tumours, is
inhibited by tumour supernatants (Rhodes
et al., 1979). It has been shown that
tumour supernatants can inhibit the
movement of macrophages both in vivo
and in vitro (Snyderman & Pike, 1976) and
we were interested to find that lung
extracts had minimal effects on monocyte
2 h adherence or maturation at 7 days, but
that tumour extracts prepared similarly
caused a substantial inhibition of matura-
tion. It is likely that whatever the tumour
produces is firmly bound to the mono-
cytes, since a significant though less
marked inhibition of maturation at 7 days
occurred after exposure of the monocytes
for only 30 min followed by 2 washes.
The data available on serum inhibitory
materials in cancer patients suggest that
no one substance, specific or nonspecific,
is responsible for the observed defects of
lymphocyte or MPS function, and that
systemic function may be very different
from the function of similar cells in the
vicinity of a tumour. The complexity of
the clinical situation may confound at-
tempts to identify direct correlations
between suppressive soluble factors and
cellular functions. Therefore it cannot be
inferred that the presence of immune
complexes or increased levels of PAG in
our patients has no importance to mono-
cyte maturation in vivo.
There have been attempts to isolate
soluble materials responsible for inhibition
of macrophage functions. The materials
described have diverse properties and
sizes (Snyderman & Pike, 1976; Brozna &
Ward, 1975; Fauve et al., 1974; Rhodes et
al., 1979; North et al., 1976) only serving
to support the contention that there are
many host- and tumour-derived materials
that can influence cellular immune func-
tion.
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patients and Dr I. Hunter and Dr W. H. Stimson
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